Letter to the Editor
Activity of RX-P873, a novel pyrrolocytosine, against Gram-negative bacteria

https://doi.org/10.1016/j.ijantimicag.2015.06.001Get rights and content

Section snippets

Funding

IHMA Europe received funding from Melinta Therapeutics for the experimental work and writing of this manuscript.

Competing interests

IM, SM, EG, PJ and SH are employees of IHMA Europe; AM and ED are employees of Melinta Therapeutics.

Ethical approval

Not required.

References (5)

  • A.K. Thabit et al.

    Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials

    Expert Opin Pharmacother

    (2015)
  • US. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013....
There are more references available in the full text version of this article.

Cited by (0)

These data were presented in part at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 5–9 September 2014, Washington, DC [abstract C-1373].

View full text